Patient Self-reported quality of life assessment in Type 2 diabetes mellitus: A pilot study

Niger J Clin Pract. 2018 Mar;21(3):343-349. doi: 10.4103/njcp.njcp_433_16.

Abstract

Background: Quality of life (QoL) is an important outcome measure to assess the diabetic care and is increasingly replacing the traditional indicators of health.

Aim: The aim is to evaluate the QoL in patients with type 2 diabetes mellitus (DM) using a third generation individualized QoL instrument like an audit of diabetes-dependent QoL (ADDQoL) questionnaire and to determine the predictors.

Materials and methods: Patients who met the inclusion and exclusion criteria were recruited from a tertiary care hospital by convenience sampling. Sociodemographic and other relevant details were collected from the study patients, and ADDQoL questionnaire were administered to them.

Results: A total of 200 patients were included in the study among which 66% of patients had uncontrolled type 2 DM as suggested by their glycated hemoglobin (HbA1c) values. The mean QoL score was 0.07 (0.91) and diabetes-dependent QoL was -1.33 (0.58). Approximately 38% were associated with poor health-related QoL with a mean average weighted impact score of -0.51 (0.51). Most frequently affected life domain was the freedom to eat. A positive correlation was observed between QoL and gender, age, domicile, education status, occupation, family structure, duration of type 2 DM, HbA1c, insulin treatment, and the presence of comorbidities.

Conclusion: The study highlights the impact of type 2 DM on QoL. Improving QoL of type 2 diabetic patients is important and knowledge of these preventable risk factors help to implement strategies to better management of type 2 DM and ultimately improve therapeutic outcome.

Keywords: India; patient-reported outcomes; quality of life; type 2 diabetes mellitus.

MeSH terms

  • Adult
  • Aged
  • Diabetes Mellitus, Type 2 / drug therapy
  • Diabetes Mellitus, Type 2 / psychology*
  • Diabetes Mellitus, Type 2 / therapy
  • Female
  • Humans
  • Hypoglycemic Agents / therapeutic use
  • India
  • Insulin / therapeutic use*
  • Male
  • Middle Aged
  • Patient Reported Outcome Measures*
  • Pilot Projects
  • Quality of Life / psychology*
  • Reproducibility of Results
  • Risk Factors
  • Self Report
  • Surveys and Questionnaires / standards*

Substances

  • Hypoglycemic Agents
  • Insulin